Hyzaar 100-25 tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FCFQ4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $99,689
Award facts
- Contract value 100% obligated
- $99,688.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $99,688.64 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Hyzaar 100-25 tablet 90-count units. The award, issued on January 27, 2026, represents a firm fixed-price delivery order with an ultimate completion date of January 28, 2026, and carries no set-aside designation, indicating the contractor competed in unrestricted federal procurement. DMS Pharmaceutical Group was selected as the awardee based on its competitive capabilities and established performance within the federal pharmaceutical supply chain.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical support to Department of Defense healthcare facilities worldwide. The parent IDC, valued at $499,999,999 with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a critical regional prime vendor contractor authorized to deliver branded and generic prescription medications, biologics, and medical consumables. The company's demonstrated performance on numerous prior delivery orders across diverse pharmaceutical categories, ranging from routine medications to specialty treatments, supports its capability to fulfill this and ongoing military medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26FCFQ4?
SPE2DR26FCFQ4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FCFQ4 worth?
The government has obligated $99,689 on SPE2DR26FCFQ4.
Is contract SPE2DR26FCFQ4 an order under another contract?
Yes. SPE2DR26FCFQ4 is a delivery order under SPE2DR25D9133, an indefinite delivery contract.
Was contract SPE2DR26FCFQ4 competed?
The extent of competition for SPE2DR26FCFQ4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award